Inventor · disambiguated record
Tave Van Zyl
Also filed as: VAN ZYL TAVE
1 granted patent·2 pending applications·0 citations·filing 2022–2024
13Inventor score
Files withREGENERON PHARMA3
Top patents by PatentIndex Score
3 records- 0168US2025115918A1Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0262US12157891B2Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitorsREGENERON PHARMA·Filed 2022·Granted Dec 3, 2024·0 cites·9 claims
- 0359US2024238384A1Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tave Van Zyl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →